Insider Transactions in Q1 2024 at Fennec Pharmaceuticals Inc. (FENC)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 26
2024
|
Chris A Rallis |
BUY
Exercise of conversion of derivative security
|
Direct |
4,329
+8.73%
|
$8,658
$2.31 P/Share
|
|
Mar 26
2024
|
Chris A Rallis |
SELL
Open market or private sale
|
Direct |
2,114
-4.91%
|
$21,140
$10.97 P/Share
|
|
Mar 26
2024
|
Robert Andrade CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
13,975
-13.22%
|
$139,750
$10.9 P/Share
|
|
Mar 25
2024
|
Robert Andrade CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
13,975
-11.67%
|
$153,725
$11.0 P/Share
|
|
Jan 05
2024
|
Robert Andrade CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
15,000
-11.13%
|
$150,000
$10.41 P/Share
|
|
Jan 04
2024
|
Robert Andrade CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
15,000
-10.02%
|
$150,000
$10.64 P/Share
|